Advertisement

Investor Relations News: Breaking Investor Relations News, Comments and Articles.

06:31 EDT 22nd May 2013 | BioPortfolio

Investor Relations News RSS

Read the latest Investor Relations News from around the world, updated every five minutes. Breaking stories from leading news and press agencies, bloggers and experts on Investor Relations.

Search or Follow Our Investor Relations News…

If you are looking for more stories, you may wish to search our extensive news archives for relevant stories: Search for More Investor Relations News.

Showing "investor relations" News Articles 1 to 25 of 8,700+

Wednesday 22nd May 2013

Wright Medical Group, Inc. to Participate in Jefferies 2013 Global Healthcare Conference

Wednesday, June 5, 2013 at 8:00 a.m. Eastern Time Wright Medical Group, Inc. (NASDAQ: WMGI) announced today that it will be participating in the Jefferies 2013 Healthcare Conference on Wednesday, June 5, 2013, at the Grand Hyatt Hotel in New York City, New York. Lance Berry, chief financial officer, will present at 8:00 a.m. Eastern Time....

Phagenesis Expands Series B Financing to $17 million

Manchester, UK – 22 May 2013 − Phagenesis, the world’s leading company in the treatment of dysphagia, has expanded its Series B financing to $17m. In 2011, Phagenesis announced a €7m Series B financing, led by Inventages Venture Capital. The increased resources will be used to launch the Phagenyx® treatment, which received its CE Mark in 2012, in new territories an...

For Bifurcation Lesions in Coronary Arteries, Medtronic's Resolute Stent Delivers Strong Long-Term Results

Three Analyses Presented at EuroPCR Demonstrate Device's Durability in Addressing Common Clinical Challenge PARIS -- May 22, 2013 -- Addressing one of the most common clinical challenges in the treatment of complex coronary artery disease, three separate analyses on the program for EuroPCR this week show how strongly the Resolute drug-eluting stent from Medtronic, Inc. (NYSE: MDT) performs...

New Lawsuit on Alleged Mirena IUD Severe Injuries: Now, AttorneyOne Can Provide Advice

According to court documents, on April 16, a Kansas resident filed a lawsuit in Kansas District Court alleging severe injuries caused by her Mirena IUD. In light of this news, AttorneyOne, a recognized authority on law, informs that they are now providing advice, including how to get in contact with legal counsel, to people potentially affected by Mirena IUD serious complications. San Diego, CA (P...

Remuda Ranch Sponsor of 6th Annual HEAL Conference

Remuda Ranch, a comprehensive treatment center specializing in eating and co-occurring disorders for women and girls, is a sponsor of the 6th Annual Healthy Eating and Living (HEAL) Conference in Asheville, N.C. from May 30-31, 2013, at the Mountain Area Health Education Center, Biltmore Campus. The theme of the conference is “A New Look at the Who, What, Where and Why of Eating Disorders.” Wi...

Acadia, NPS, Ironwood sell more than $300m in stock

Large stock offerings by three publicly traded drug developers are testing the investor love affair with industry during a year in which the Nasdaq Biotechnology Index has skyrocketed 73% from 1094.71 on 3 January to 1893.44 as of 21 May. On.....

Assured Pharmacy Hires Hayden IR

PLANO, Texas, May 22, 2013 /PRNewswire/ -- Assured Pharmacy, Inc. (APHY), a leading pharmacy group that specializes in providing prescription medications to sufferers of chronic pain, announced it has engaged Hayden IR, a fifteen-year old, highly recognized, national investor relations firm, to raise its visibility and strengthen its relationships with the investment community. "Over the...

Elbit Imaging Announces the Court Decision with Respect to Filing of Plan of Arrangement with the Israeli Court

TEL AVIV, Israel, May 22, 2013 /PRNewswire/ -- Elbit Imaging Ltd. ("EI" or the "Company") (TASE, NASDAQ: EMITF) announced today, further to the Company's announcement dated May 9, 2013 that it had filed a motion with the Tel Aviv District Court (the "Court") to convene meetings of its unsecured creditors and shareholders for the approval of the proposed restructuring of the Company's unsecured fi...

CEO of Immune Pharmaceuticals to Present at BioEquity Europe 2013

UPDATE ON BERTILIMUMAB DEVELOPMENT AND EPICEPT MERGER PROCESS Regulatory News: Immune Pharmaceuticals Ltd. (“Immune”), a privately held Israeli company, and EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT) announced today that Daniel Teper, Chief Executive Officer of Immune, will be presenting at the BioEquity Europe 201...

Tuesday 21st May 2013

CORRECTING and REPLACING InVivo Therapeutics Announces Webcast for Annual Shareholders Meeting to Be Held on May 23rd

Please replace the release dated May 17, 2013 with the following corrected version due to multiple revisions. The corrected release reads: INVIVO THERAPEUTICS ANNOUNCES WEBCAST FOR ANNUAL SHAREHOLDERS MEETING TO BE HELD ON MAY 23RD InVivo Therapeutics Holdings Corp. (NVIV), a developer of groundbreaking technologies for th...

VCA Antech, Inc. to Present at Jefferies 2013 Global Healthcare Conference

VCA Antech, Inc. (NASDAQ: WOOF), a leading animal healthcare company in the United States, will present at the Jefferies 2013 Global Healthcare Conference on Tuesday, June 4th, in New York City. The VCA Antech, Inc. presentation is scheduled to begin at 2:00 pm Eastern. VCA Antech, Inc. will make a presentation on the company, including...

DelMar Pharmaceuticals To Present At The Second Annual Marcum LLP MicroCap Conference

VANCOUVER, Canada and MENLO PARK, Calif., May 20, 2013 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) announced today that Jeffrey Bacha, president and CEO, will present at the Second Annual Marcum LLP MicroCap Conference on Thursday, May 30, 2013 in New York City at the Grand Hyatt Hotel. The Company's presentation is scheduled to begin at 11:30 a.m. EDT and will be available v...

ArthroCare Announces Participation in Investor Conference

ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, announced today participation in an upcoming investor conference, as detailed below. On Wednesday, May 29, 2013 ArthroCare will attend the 10th Annual Craig - Hallum Institutional Investor Conference. Please see the conference details be...

[Kite Pharma] completes $35mm Series A round

[Kite Pharma Inc.] (targeted immunotherapeutics for cancer) raised $35mm through its Series A round. New investor Alta Partners participated, along with all returning major backers including company executive chairman Arie Belldegrun, MD, Pontifax, C...

Lakeland Industries Management Discusses Q4 2013 Results - Earnings Call Transcript

Lakeland Industries (LAKE) Q4 2013 Earnings Call May 21, 2013 4:30 pm ET Executives Christopher J. Ryan - Chief Executive Officer, President, Secretary and Director Gary Pokrassa - Chief Financial Officer Analysts Quinton Mathews Douglas Ruth Presentation Operator Good afternoon and welcome to the Lakeland Industries Investor Conference Call. [Operator Instructions] Please note th...

Audax Group Announces Acquisition of Chesapeake IRB

Audax Group announced it has completed the recapitalization of Chesapeake Research Review, Inc., d/b/a Chesapeake IRB (“Chesapeake”). Headquartered in Columbia, Maryland, Chesapeake is a leading provider of independent institutional review board (“IRB”) services to major pharmaceutical, biotech and medical device companies, universities, academic m...

Ogilvy Public Relations Receives Grand Challenges Explorations Grant For Groundbreaking Research in Global Health and Development

SAN FRANCISCO, May 21, 2013 /PRNewswire/ -- Ogilvy Public Relations announced today that it is a Grand Challenges Explorations winner, an initiative funded by the Bill & Melinda Gates Foundation.  Ogilvy PR will pursue an innovative global health and development research project, titled "Cause Generation: A Platform to Define a Generation's Cause." Grand Challenges Explorations (GCE...

Jazz Pharmaceuticals Public Limited Company Presents at UBS Global Healthcare Conference, May-21-2013 09:30 AM

Jazz Pharmaceuticals, Inc. (JAZZ) May 21, 2013 9:30 am ET Executives Kathryn E. Falberg - Chief Financial Officer and Executive Vice President Analysts Ami Fadia - UBS Investment Bank, Research Division Presentation Ami Fadia - UBS Investment Bank, Research Division Good morning, everybody. Thanks for coming to the UBS Conference. I'm Ami Fadia. I cover mid-cap spec pharma stocks...

Aeterna Zentaris Announces "At-the-Market" Issuance Program

QUEBEC CITY, May 21, 2013 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS; TSX: AEZ)  (the "Company"), announced today that it has entered into an "At Market" Issuance ("ATM") Sales Agreement, dated May 21, 2013, with MLV & Co. LLC ("MLV"), under which the Company may, at its discretion, from time to time during the term of the sales agreement, sell up to a maximum of  2.5 m...

BIO Issues Call for Paper and Panel Submissions for 2013 Pacific Rim Summit on Industrial Biotech and Bioenergy

The Biotechnology Industry Organization (BIO) invites leaders from the biotechnology, chemical and agricultural industries to submit proposals and abstracts for panels, individual papers and posters for the 2013 Pacific Rim Summit on Industrial Biotechnology and Bioenergy. This unique conference will be held Dec. 8-11, 2013 in San Diego. Participa...

Labor Commissioner Cites Adult Care Facilities Nearly $600,000 for Wage Theft Violations

OAKLAND, Calif., May 21, 2013 /PRNewswire-USNewswire/ -- California Labor Commissioner Julie A. Su issued citations totaling $584,635.97 to three Bay Area-based adult care facilities for wage theft, including minimum wage, overtime and meal break violations. Two of the three facilities cited, Dream Care, LLC, dba Evergreen Terrace of San Ramon and New Hope Community Care, Inc. dba Angela's...

European Medicines Agency (EMA) Accepts Veloxis' Marketing Authorization Application (MAA) for LCP-Tacro for Treatment of Kidney Transplant Patients

HORSHOLM, Denmark, May 21, 2013 /PRNewswire/ -- Veloxis Pharmaceuticals A/S (OMX: VELO)  today announced that the European Medicines Agency (EMA) accepted for review the company's Marketing Authorization Application (MAA) to market LCP-Tacro for the prevention of organ rejection in kidney transplant patients in the European Union. Veloxis expects the decision from the European Union in 2014....

Sonova Holding's CEO Discusses Full-Year 2012/2013 Results - Earnings Call Transcript

Sonova Holding Ag (SONVF.PK) Full-Year 2012/2013 Results Earnings Call May 21, 2013 7:00 AM ET Executives Thomas Bernhardsgruetter – Head, IR Lukas Braunschweiler – CEO Hartwig Grevener – CFO Analysts Chris Gretler – Credit Suisse Oliver Metzger – Commerzbank Florian Gaiser – BZ Bank Lorenz Reinhard – Pictet Asset Management Hendrik Lofruthe – HSBC Presentation Th...

Kindred Healthcare Inc. - Analyst/Investor Day

Kindred Healthcare, Inc. (KND) May 21, 2013 10:00 am ET Executives Paul J. Diaz - Chief Executive Officer, Director and Chairman of Strategic Development Committee Benjamin A. Breier - President and Chief Operating Officer William M. Altman - Executive Vice President for Strategy, Policy and Integrated Care Gregory C. Miller - Chief Development Officer Richard A. Lechleiter - Chief Financial O...

Regulus to Present at Deutsche Bank 38th Annual Healthcare Conference

LA JOLLA, Calif., May 21, 2013 /PRNewswire/ -- Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today announced that Garry E. Menzel, Ph.D., Chief Operating Officer and Executive Vice President, Finance, will present a company overview at the Deutsche Bank 38th Annual Healthcare Conference...


Search BioPortfolio:
Advertisement

News Quicklinks

Advertisement